Savara Management
Management criteria checks 2/4
Savara's CEO is Matt Pauls, appointed in Sep 2020, has a tenure of 3.58 years. total yearly compensation is $2.20M, comprised of 26.4% salary and 73.6% bonuses, including company stock and options. directly owns 0.37% of the company’s shares, worth €2.10M. The average tenure of the management team and the board of directors is 2.6 years and 7 years respectively.
Key information
Matt Pauls
Chief executive officer
US$2.2m
Total compensation
| CEO salary percentage | 26.4% |
| CEO tenure | 3.6yrs |
| CEO ownership | 0.4% |
| Management average tenure | 2.6yrs |
| Board average tenure | 7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$55m |
| Sep 30 2023 | n/a | n/a | -US$49m |
| Jun 30 2023 | n/a | n/a | -US$43m |
| Mar 31 2023 | n/a | n/a | -US$40m |
| Dec 31 2022 | US$2m | US$580k | -US$38m |
| Sep 30 2022 | n/a | n/a | -US$39m |
| Jun 30 2022 | n/a | n/a | -US$39m |
| Mar 31 2022 | n/a | n/a | -US$41m |
| Dec 31 2021 | US$2m | US$560k | -US$43m |
| Sep 30 2021 | n/a | n/a | -US$45m |
| Jun 30 2021 | n/a | n/a | -US$46m |
| Mar 31 2021 | n/a | n/a | -US$44m |
| Dec 31 2020 | US$2m | US$170k | -US$50m |
| Sep 30 2020 | n/a | n/a | -US$68m |
| Jun 30 2020 | n/a | n/a | -US$69m |
| Mar 31 2020 | n/a | n/a | -US$81m |
| Dec 31 2019 | US$64k | n/a | -US$78m |
| Sep 30 2019 | n/a | n/a | -US$57m |
| Jun 30 2019 | n/a | n/a | -US$57m |
| Mar 31 2019 | n/a | n/a | -US$47m |
| Dec 31 2018 | US$114k | n/a | -US$62m |
| Sep 30 2018 | n/a | n/a | -US$58m |
| Jun 30 2018 | n/a | n/a | -US$52m |
| Mar 31 2018 | n/a | n/a | -US$53m |
| Dec 31 2017 | US$75k | n/a | -US$31m |
Compensation vs Market: Matt's total compensation ($USD2.20M) is above average for companies of similar size in the German market ($USD1.30M).
Compensation vs Earnings: Matt's compensation has increased whilst the company is unprofitable.
CEO
Matt Pauls (52 yo)
3.6yrs
Tenure
US$2,195,542
Compensation
Mr. Matthew Pauls, J.D. M.B.A. also known as Matt, is Director at NVN Liquidation Inc. He serves as Director of Soleno Therapeutics, Inc. since August 15, 2023. He serves as Chief Executive Officer at Sava...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 3.6yrs | US$2.20m | 0.37% $ 2.1m | |
| CFO, Chief Administrative Officer & Secretary | 7.4yrs | US$1.05m | 0.060% $ 339.5k | |
| Chief Medical Officer | 1.4yrs | US$698.69k | 0.0072% $ 41.2k | |
| Chief Operating Officer | 1.2yrs | no data | 0% $ 0 | |
| Senior VP & General Counsel | 6.1yrs | no data | no data | |
| Chief Business Officer | 3.5yrs | no data | 0.084% $ 476.4k | |
| Head of Clinical Operations | 2.9yrs | no data | no data | |
| Senior Vice President of Global Regulatory Affairs & Quality Assurance | 2.7yrs | no data | no data | |
| Executive Vice President of Global Technical Operations | 2.6yrs | no data | no data | |
| Executive Vice President of Global Commercial | 1.3yrs | no data | no data | |
| Senior VP of Global Medical Affairs | less than a year | no data | no data | |
| Senior VP & Head of Clinical Development | less than a year | no data | no data |
2.6yrs
Average Tenure
57.5yo
Average Age
Experienced Management: YB4P's management team is considered experienced (2.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 7yrs | US$2.20m | 0.37% $ 2.1m | |
| Independent Director | 7yrs | US$104.30k | 1.59% $ 9.1m | |
| Lead Independent Director | 10.5yrs | US$101.30k | 0.12% $ 694.0k | |
| Independent Director | 13.5yrs | US$95.30k | 0.0092% $ 52.5k | |
| Independent Director | 15.2yrs | US$103.80k | 0% $ 0 | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Independent Director | 4.3yrs | US$90.80k | 0% $ 0 | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Independent Director | 4.3yrs | US$101.80k | 0% $ 0 | |
| Member of Clinical Advisory Board | 3.3yrs | no data | no data | |
| Member of Clinical advisory Board | 1.3yrs | no data | no data |
7.0yrs
Average Tenure
58yo
Average Age
Experienced Board: YB4P's board of directors are considered experienced (7 years average tenure).